SUPER C 1000

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

rutoside, Quantity: 50 mg; Citrus bioflavonoids extract, Quantity: 100 mg; hesperidin, Quantity: 50 mg; calcium ascorbate, Quantity: 1000 mg (Equivalent: ascorbic acid, Qty 826 mg)

Disponível em:

Australian Naturalcare Products Pty Ltd

DCI (Denominação Comum Internacional):

calcium ascorbate,Citrus bioflavonoids extract,Hesperidin,rutoside

Forma farmacêutica:

Tablet, film coated

Composição:

Excipient Ingredients: hypromellose; macrogol 8000; povidone; iron oxide yellow; magnesium stearate; titanium dioxide; Carnauba Wax; tartaric acid; crospovidone; microcrystalline cellulose

Via de administração:

Oral

Indicações terapêuticas:

Antioxidant/Reduce free radicals formed in the body ; Helps reduce/decrease free radical damage to body cells ; Maintain/support collagen formation ; Maintain/support collagen health ; Maintain/support general health and wellbeing ; Maintain/support connective tissue health ; Aid/assist/helps connective tissue production/formation ; Maintain/support blood capillary health ; Maintain/support healthy immune system function ; Helps stimulate a healthy immune system response ; Helps enhance/promote/increase absorption of dietary (state vitamin/mineral/nutrient) ; Maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; Helps reduce occurrence of common colds ; Decrease/reduce/relieve common cold duration ; Helps decrease/reduce/relieve the severity of symptoms of common colds and flu ; Decrease/reduce/relieve symptoms of common colds and flu ; Decrease/reduce/relieve symptoms of head cold ; Decrease/reduce/relieve the severity of symptoms of mild upper respiratory tract infections ; Maintain/support wound healing

Resumo do produto:

Visual Identification: ;

Status de autorização:

Licence status A

Data de autorização:

2017-03-17